← Back to Clinical Trials
Recruiting NCT06152328

NCT06152328 Virtual Reality Based Mirror Therapy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06152328
Status Recruiting
Phase
Sponsor Abant Izzet Baysal University
Condition Stroke
Study Type INTERVENTIONAL
Enrollment 56 participants
Start Date 2024-04-01
Primary Completion 2026-05-02

Eligibility & Interventions

Sex All sexes
Min Age 40 Years
Max Age 80 Years
Study Type INTERVENTIONAL
Interventions
Virtual reality applications based on mirror therapyConventional treatmentMirror therapy

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 56 participants in total. It began in 2024-04-01 with a primary completion date of 2026-05-02.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study is to examine the effectiveness of 3D virtual reality assisted mirror therapy based rehabilitation applications compared to classical methods used in stroke rehabilitation.

Eligibility Criteria

Inclusion Criteria: * Have a ischemic stroke * Stroke duration not less than 2 months and not more than 6 months * Individuals with a score of 2b and 3 according to the Thrombolysis in cerebral infarction (TICI) scale * A score of 2 and above according to the upper extremity motor assessment of the NIH stroke scale * Intact depth perception in the Titmus Stereopsis assessment * A score of 24 and above in the Mini-mental test and * Independent sitting balance Exclusion Criteria: * Additional neurologic diseases * Have a head injury * Have a brain tumor * Prior cranial surgery * Psychological disorder or mental problem * Previous stroke * Aphasia and apraxia * Upper extremity amputation

Contact & Investigator

Central Contact

Ramazan Kurul, Ph.D

✉ ramazankurul2@hotmail.com

📞 (0374) 254 10 00

Principal Investigator

Ramazan Kurul, Ph.D

PRINCIPAL INVESTIGATOR

Abant Izzet Baysal University

Frequently Asked Questions

Who can join the NCT06152328 clinical trial?

This trial is open to participants of all sexes, aged 40 Years or older, up to 80 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06152328 currently recruiting?

Yes, NCT06152328 is actively recruiting participants. Contact the research team at ramazankurul2@hotmail.com for enrollment information.

Where is the NCT06152328 trial being conducted?

This trial is being conducted at Bolu, Turkey (Türkiye).

Who is sponsoring the NCT06152328 clinical trial?

NCT06152328 is sponsored by Abant Izzet Baysal University. The principal investigator is Ramazan Kurul, Ph.D at Abant Izzet Baysal University. The trial plans to enroll 56 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology